Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Aerobic Versus Resistance Exercises on Disability After Abdominal Myomectomy (RE)

16 de junho de 2026 atualizado por: Norhan Khalaf Awad Ahmed, Cairo University
This study will be conducted to compare aerobic and resistance exercises on disability after abdominal myomectomy.

Visão geral do estudo

Status

Ainda não está recrutando

Condições

Descrição detalhada

Abdominal myomectomy is a classic surgery for uterine fibroids removal without removing the uterus, in line to reserve patients' fertility. Uterine fibroids are the most common uterus non-cancerous tumors with a prevalence of 70% to 80% in women. Although only 25% to 30% of women are affected by symptoms like pelvic pain, pressure, heavy menses, recurrent pregnancy loss, and infertility, it remains the leading indication for hysterectomy and a common women's health concern. No doubt that abdominal myomectomy almost recommended preserving fertility, plus alleviating uterine fibroids clinical manifestations without resorting to a hysterectomy.Recent studies have explored the combined effects of aerobic and resistance exercises as part of a comprehensive rehabilitation program. Research suggests that combining aerobic and resisted exercise training might gain superior functional benefits compared to using one exercise training program. A recent clinical trial conducted by demonstrated that combination of aerobic and resistance exercises almost represented with reduced fatigue symptoms, which resulted in better improved overall functional capacity, and earlier recovery in compared to those who engaged in only one exercise training protocol. The rationale behind this combination approach is that aerobic exercise improves cardiovascular fitness and endurance, while resistance training focuses on building muscle strength and improving muscular endurance, providing a more holistic approach to recover.

Finally, postoperative rehabilitation following myomectomy must also consider the prevention of complications such as abdominal scarring, hernias, and pelvic floor dysfunction, which can arise as a result of the surgery. Aerobic and resistance exercises have been shown to play a crucial role in minimizing these risks by promoting muscle strength, enhancing tissue healing, and improving flexibility. Research suggests that exercise can stimulate tissue remodeling and improve the elasticity of the abdominal wall, which reduces the likelihood of the formation of problematic scars or hernias. Furthermore, aerobic and resistance exercises support the pelvic floor muscles, helping to prevent dysfunction and incontinence, which are common concerns following abdominal surgeries like myomectomy. By addressing both muscular strength and flexibility, a balanced approach to rehabilitation can enhance recovery and reduce the risk of long-term complications.

Tipo de estudo

Intervencional

Inscrição (Estimado)

60

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto

Aceita Voluntários Saudáveis

Não

Descrição

Inclusion Criteria:

  • All patients are conscious and ambulant.
  • Their ages ranged from 30-60 years old.
  • All patients will be under post abdominal myomectomy (6-12 months) management program.
  • All patients will not suffer from any complication post abdominal myomectomy, except weakness of abdominal muscles.
  • All patients will receive and agreed to sign the informed consent form.

Exclusion Criteria:

  • The patient who has cardiovascular diseases, or uncontrolled hypertension.
  • The patient who has cardiac pacemakers or other implanted electronic devices.
  • Uncooperative patients.
  • Patients who have cardiopulmonary diseases.
  • Patients who have psychic disorders.
  • Patients with neuromuscular diseases.
  • Pregnant female.
  • Patients who have any endocrine, metabolic, renal or hepatic diseases. Patients who have an open wound at or near the treatment site.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: aeropic exercises
Thirty patients who have undergone abdominal myomectomy will receive resisted exercises program for, 3 sessions per week for 12 weeks in addition to the routine medical treatment
  • Treadmill Walking: will begin at a low speed and incline, progressing gradually based on endurance.
  • Stationary Cycling: Low resistance cycling, will focus on steady, rhythmic pedaling.
  • Step Aerobics: Low-impact stepping movements to music, with a focus on maintaining proper posture.

    • The workload was increased incrementally by adjusting: Speed (walking/cycling pace), Resistance (stationary cycling or water exercises), Duration (gradually increasing from 20 to 30 minutes for the main session), Intensity progression was based on the Rate of Perceived Exertion (RPE) or patient-reported effort, ensuring safe advancement.
Experimental: Resistance Exercises
thirty patients who have undergone abdominal myomectomy will receive aerobic exercises program for, 3 sessions per week for 12 weeks in addition to the routine medical treatment

The patient will be prepared with preparatory explanations about each tool will be utilized i.e., sand bags, thera Bands, and swiss ball.Twelve exercises will be utilized for 12 weeks, three sessions/ week.

The intervention will be applied by a trained physical therapist. First of all, each participant will be instructed to relax thighs, bottom and abdomen musculature.Each participant will be able to do 10 slow contractions each time, holding them for 10 seconds each with rests of 4 seconds in between. Then do not hold your breath or tighten rectus abdominis muscles at the same time. Will instruct participants to try holding each squeeze for a few seconds utilizing sand bags, thera band, and swiss balls.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
functional disability
Prazo: up to 12 weeks
Functional Independence Measure Scale was used to assess functional disability. it includes 18 items divided into two domains: Motor tasks (13 items) and cognitive tasks (5 items). score (1-7) to each of the 18 items based on the patient's observed performance.-Total FIM score range: 18 (complete dependence) to 126 (complete independence).
up to 12 weeks
pain intensity
Prazo: up to 12 weeks
Visual analogue scale consisted of a line, usually 100mm long, the patient was instructed to place a vertical mark on to indicate his pain, ranging from no pain or discomfort (0), to the worst pain (100) that the patient could feel
up to 12 weeks

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
rectus abdominal muscle strength
Prazo: up to 12 weeks
The manual muscle test is a valid and reliable dependent in assessment of musculoskeletal musculatures obtained using the procedure. Each dimension is rated on a 7-point scale: 7 is complete independence, 6 is modified independence, 5 equals supervision or setup, 4 equals minimal contact assistance (client expends 75% or more of the effort), 3 is moderate assistance (client expends between 50% and 75% of the effort), 2 is maximal assistance (client expends between 25% and 50% of the effort), and 1 equals total assistance (client expends <25% of the effort).
up to 12 weeks

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

25 de junho de 2026

Conclusão Primária (Estimado)

30 de outubro de 2026

Conclusão do estudo (Estimado)

30 de outubro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

16 de junho de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

16 de junho de 2026

Primeira postagem (Real)

22 de junho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

22 de junho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

16 de junho de 2026

Última verificação

1 de junho de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • P.T.REC/012/005921

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever